FIBROGEN INCFIBROGEN INCFIBROGEN INC

FIBROGEN INC

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−6.93MXN
Revenue estimate
‪607.64 M‬MXN
Market capitalization
‪1.78 B‬MXN
−49.69MXN
‪−4.83 B‬MXN
‪2.51 B‬MXN
‪92.49 M‬
Beta (1Y)
3.24

About FibroGen, Inc

CEO
Thane Wettig
Headquarters
San Francisco
Employees (FY)
486
Founded
1993
FIGI
BBG00JX0QGH9
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of FGEN is 22.10 MXN — it has increased by 1.52% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange FIBROGEN INC stocks are traded under the ticker FGEN.
FIBROGEN INC is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
FGEN stock is 1.51% volatile and has beta coefficient of 3.24. Check out the list of the most volatile stocks — is FIBROGEN INC there?
FGEN earnings for the last quarter are −11.33 MXN per share, whereas the estimation was −11.87 MXN resulting in a 4.56% surprise. The estimated earnings for the next quarter are −7.22 MXN per share. See more details about FIBROGEN INC earnings.
FIBROGEN INC revenue for the last quarter amounts to ‪699.56 M‬ MXN despite the estimated figure of ‪642.14 M‬ MXN. In the next quarter revenue is expected to reach ‪660.73 M‬ MXN.
Yes, you can track FIBROGEN INC financials in yearly and quarterly reports right on TradingView.
FGEN stock has risen by 1.98% compared to the previous week, the month change is a 32.35% fall, over the last year FIBROGEN INC has showed a 25.26% decrease.
FGEN net income for the last quarter is ‪−955.11 M‬ MXN, while the quarter before that showed ‪−1.11 B‬ MXN of net income which accounts for 13.87% change. Track more FIBROGEN INC financial stats to get the full picture.
Today FIBROGEN INC has the market capitalization of ‪1.78 B‬, it has decreased by 11.47% over the last week.
No, FGEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, FGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FIBROGEN INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 28, 2024, the company has 486.00 employees. See our rating of the largest employees — is FIBROGEN INC on this list?
We've gathered analysts' opinions on FIBROGEN INC future price: according to them, FGEN price has a max estimate of 24.84 MXN and a min estimate of 24.84 MXN. Read a more detailed FIBROGEN INC forecast: see what analysts think of FIBROGEN INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FIBROGEN INC EBITDA is ‪−4.40 B‬ MXN, and current EBITDA margin is −175.48%. See more stats in FIBROGEN INC financial statements.